BREAKING
Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap 2 minutes ago LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected 6 minutes ago UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings 10 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap 20 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings 23 minutes ago COMPASS Pathways plc (CMPS) Reports Q4 Earnings 34 minutes ago Core & Main, Inc. (CNM) Misses Q4 EPS Estimates by 32.3% 38 minutes ago Concentrix Corporation (CNXC) Misses Q1 EPS Estimates 44 minutes ago Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% 50 minutes ago Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected 1 hour ago Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap 2 minutes ago LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected 6 minutes ago UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings 10 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap 20 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings 23 minutes ago COMPASS Pathways plc (CMPS) Reports Q4 Earnings 34 minutes ago Core & Main, Inc. (CNM) Misses Q4 EPS Estimates by 32.3% 38 minutes ago Concentrix Corporation (CNXC) Misses Q1 EPS Estimates 44 minutes ago Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% 50 minutes ago Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected 1 hour ago
ADVERTISEMENT
Market News

Philip Morris’ (PM) smoke-free business surges ahead in Q1 2025 fueled by ZYN

Shares of Philip Morris International Inc. (NYSE: PM) gained over 2% on Wednesday, after the company delivered solid results for Q1 2025 and raised its outlook for the full year. The robust quarterly performance was driven by strong momentum in the smoke-free business, fueled by ZYN and IQOS. Better-than-expected results Philip Morris’ net revenues increased […]

April 23, 2025 2 min read

Shares of Philip Morris International Inc. (NYSE: PM) gained over 2% on Wednesday, after the company delivered solid results for Q1 2025 and raised its outlook for the full year. The robust quarterly performance was driven by strong momentum in the smoke-free business, fueled by ZYN and IQOS. Better-than-expected results Philip Morris’ net revenues increased […]

Shares of Philip Morris International Inc. (NYSE: PM) gained over 2% on Wednesday, after the company delivered solid results for Q1 2025 and raised its outlook for the full year. The robust quarterly performance was driven by strong momentum in the smoke-free business, fueled by ZYN and IQOS.

Better-than-expected results

Philip Morris’ net revenues increased 5.8% to $9.3 billion in the first quarter of 2025 compared to the same period a year ago. Organic revenue growth was 10.2%. Reported earnings per share grew 24.6% year-over-year to $1.72 while adjusted EPS rose 12.7% to $1.69. Both the top and bottom line numbers beat expectations.  

Stellar smoke-free performance

PM’s smoke-free business delivered a solid performance in Q1 2025, with a 15% growth in revenues and a 27.7% rise in gross profit. Shipment volumes were up 14.4%. This segment now accounts for 42% of total revenues and 44% of total gross profit. The company’s smoke-free products are available in 95 markets and it has expanded its multi-category smoke-free portfolio to 46 markets.

The smoke-free momentum was driven by growth in ZYN and IQOS. ZYN nicotine pouches saw shipments in the US increase by 53% to 202 million cans. Outside the US, nicotine pouch volume in cans also grew 53%. During the quarter, shipments almost trebled outside the Nordics and the product is gaining traction in markets like Austria and Switzerland.

IQOS heated tobacco units (HTU) adjusted in-market sales (IMS) volume grew 9.4% in Q1, with strong performance in Japan and Europe. The company expects double-digit growth for the remainder of the year.

Resilience in combustibles

Revenues in the combustibles segment remained flat YoY in Q1 2025 but rose 3.8% on an organic basis, helped by volume growth and strong pricing, partly offset by negative geographic mix. Gross profit grew 2% on a reported basis and 5.3% organically. Cigarette volumes were positive and the company continued to see growth in markets where smoke-free products are not permitted. Marlboro continued to gain market share in the quarter and PM’s overall cigarette category share increased to 24.8%.

Raised profit outlook

Philip Morris raised its earnings outlook for the full year of 2025 and now expects reported EPS to range between $7.01-7.14 and adjusted EPS to range between $7.36-7.49. It continues to expect organic revenue growth of 6-8% for the year.

ADVERTISEMENT